Endonovo Therapeutics, Inc.
Endonovo Therapeutics, Inc. (ENDV) Stock Overview
Explore Endonovo Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Company Profile
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiovascular diseases, chronic kidney diseases, liver diseases, non-alcoholic steatohepatitis, peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Mr. Alan Brian Collier
1
6320 Canoga Avenue, Woodland Hills, CA
2012